ARDS Clinical Trial
— MISMATCHED FROfficial title:
Effect of PEEP on Ventilartion/Perfusion Ratios According to Different Phenotypes in Patients With ARDS (France)
Verified date | October 2022 |
Source | University Hospital, Angers |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This study aim to compare the effect of Positive End Expiratory Pressure (PEEP) on ventilation/perfusion mismatch in two phenotypes of patients with moderate-to-severe Acute Respiratory Distress Syndrome (ARDS), characterized by their respiratory system elastance (Ers). Ventilation/perfusion mismatch will be assessed by Electrical Impedance Tomography (EIT).
Status | Not yet recruiting |
Enrollment | 50 |
Est. completion date | April 2026 |
Est. primary completion date | October 2025 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion criteria: - intubated patients with moderate and severe ARDS (Berlin definition, PaO2/FiO2 =200 mmHg at PEEP 5 cmH2O) - undergoing deep sedation - on controlled mechanical ventilation - between 24 hours and 5 days after intubation. Exclusion criteria: - age <18 years old; pregnancy - patient undergoing legal protection - contra-indications to EIT (e. g. severe chest trauma or wounds) - pneumothorax; patient undergoing ECMO - patient with BMI =35 kg/m2 - hemodynamic instability with MAP <60 mmHg despite vasopressors. |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
University Hospital, Angers |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Difference in ventilation/perfusion mismatch between PEEP 5 and 15 cmH2O according to the two studied phenotypes | Ventilation/perfusion (V/Q) mismatch will be assessed by Electrical Impedance Tomography (EIT). Mismatch is expressed in %. Comparison between phenotype with higher and lower elastance will be performed. | immediately after each intervention | |
Secondary | Difference in respiratory mechanics between PEEP 5 and 15 cmH2O according to the two studied phenotypes | Plateau pressure and total PEEP will be aggregated to compute driving pressure (Plateau pressure minus total PEEP, all in cmH2O). Respiratory system compliance will be computed by dividing tidal volume by driving pressure (in mL.cmH2O-1; respiratory system resistance will be computed as the inverse of compliance; all these values will be assessed and compared between the two PEEP levels. Comparison between phenotype with higher and lower elastance will be performed. | immediately after each intervention | |
Secondary | Difference in oxygenation between PEEP 5 and 15 cmH2O according to the two studied phenotypes | PaO2 (in mmHg) will be assessed and compared between the two PEEP levels. Comparison between phenotype with higher and lower elastance will be performed. | immediately after each intervention | |
Secondary | Difference in carbon clearance between PEEP 5 and 15 cmH2O according to the two studied phenotypes | PaCO2 (in mmHg) will be assessed and compared between the two PEEP levels. Ventilatory ratio (no unit) will be derived from the PaCO2 values. Comparison between phenotype with higher and lower elastance will be performed. | immediately after each intervention | |
Secondary | Difference in dead space measured by capnometric volumetry between PEEP 5 and 15 cmH2O according to the two studied phenotypes | VCO2 (measured by Vcap, in mmHg) will be assessed and compared between the two PEEP levels. Comparison between phenotype with higher and lower elastance will be performed. | immediately after each intervention | |
Secondary | Difference in dead space measured by calorimetry between PEEP 5 and 15 cmH2O according to the two studied phenotypes | VCO2 (measured by calorimetry, in mmHg) will be assessed and compared between the two PEEP levels. Comparison between phenotype with higher and lower elastance will be performed. | immediately after each intervention | |
Secondary | Difference in venous oxygen saturation between PEEP 5 and 15 cmH2O according to the two studied phenotypes | SvO2 (in %) will be assessed and compared between the two PEEP levels. Comparison between phenotype with higher and lower elastance will be performed. | immediately after each intervention | |
Secondary | Correlation between V/Q mismatch markers and recruitability | Recruitability will be assessed between 15 and 5 cmH2O by respiratory mechanics and EIT, as the recruited volumes value (in mL). R/I ratio will be derived from these data (no unit). V/Q mismatch will be computed by EIT, and expressed in %. Correlation will be performed by linear regression. | immediately after each intervention | |
Secondary | Correlations between V/Q mismatch assessed by EIT and dead space markers | Dead space will be assessed by volumetric capnography (if available), venrtilatory ratio, and calorimetriy (if available). V/Q mismatch will be computed by EIT, and expressed in %. Correlation will be performed by linear regression. | immediately after each intervention | |
Secondary | Correlations between V.Q mismacth and overdisension and lung collapsus | Overdistension (%) and lung collapsus (%) will be assessed during the Step 3, by EIT. These two values cannot be measured separately. V/Q mismatch will be computed by EIT, and expressed in %. Correlation will be performed by linear regression. | immediately after each intervention | |
Secondary | Difference in stress index between PEEP 5 and 15 cmH2O according to the two studied phenotypes | stress index (no unit) will be assessed and compared between the two PEEP levels. Comparison between phenotype with higher and lower elastance will be performed. | immediately after each intervention |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04435613 -
Clinical and Physiological Assessment of a Nearly Ultra-protective Lung Ventilation Strategy: A Quasi-experimental Preliminary Study in ARDS Patients
|
N/A | |
Enrolling by invitation |
NCT05020210 -
Effect of Early Treatment With Sivelestat Sodium in ARDS Patients
|
||
Completed |
NCT04468971 -
REgulatory T Cell infuSion fOr Lung Injury Due to COVID-19 PnEumonia
|
Phase 1 | |
Completed |
NCT04505592 -
Tenecteplase in Patients With COVID-19
|
Phase 2 | |
Completed |
NCT04493242 -
Extracellular Vesicle Infusion Treatment for COVID-19 Associated ARDS
|
Phase 2 | |
Withdrawn |
NCT04909879 -
Study of Allogeneic Adipose-Derived Mesenchymal Stem Cells for Non-COVID-19 Acute Respiratory Distress Syndrome
|
Phase 2 | |
Completed |
NCT02265198 -
Relationship of Pulmonary Contusion to Pulmonary Inflammation and Incidence of Acute Respiratory Distress Syndrome
|
N/A | |
Completed |
NCT01949272 -
Optimization of PEEP for Alveolar Recruitment in ARDS
|
N/A | |
Not yet recruiting |
NCT01668368 -
Goal Directed Mechanical Ventilation Aimed at Optimal Lung Compliance
|
N/A | |
Completed |
NCT01881061 -
Lung Sonography in Patients With Acute Respiratory Distress Syndrome in Intensive Care Unit
|
N/A | |
Completed |
NCT00808691 -
Microcirculation and Oxidative Stress in Critical Ill Patients in Surgical Intensive Care Unit
|
N/A | |
Completed |
NCT05035589 -
The Effect of Tocilizumab on Procalcitonin and Other Biochemical and Clinical Markers in the Setting of COVID-19 Pneumonia
|
||
Recruiting |
NCT04764032 -
Right Ventricular Dysfunction in Ventilated Patients With COVID-19
|
||
Completed |
NCT04556513 -
Functional Recovery From Acute Respiratory Distress Syndrome (ARDS) Due to COVID-19: Influence of Socio-Economic Status
|
||
Recruiting |
NCT06036056 -
NMR Based Metabolomics Kinetics in ARDS Patients
|
||
Recruiting |
NCT04503876 -
Effects of End-expiratory Positive Pressure Optimization in Intubated Patients With Healthy Lung or Acute Respiratory Distress Syndrome
|
N/A | |
Recruiting |
NCT04643691 -
Losartan and Spironolactone Treatment for ICU Patients With COVID-19 Suffering From ARDS
|
Phase 2 | |
Completed |
NCT04395911 -
Safety and Efficacy of SCD in AKI or ARDS Patients Associated With COVID-19 Infections
|
N/A | |
Not yet recruiting |
NCT05341687 -
Prognostic Value of Respiratory System Compliance Under VV-ECMO on 180-day Mortality in COVID-19 ARDS.
|
||
Recruiting |
NCT05056090 -
Effect of Prone Positioning on Mortality in Patients With Mild to Moderate Acute Respiratory Distress Syndrome.
|
N/A |